Clinical Trial Update: Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immune responses of two investigational RNA-based vaccines against tuberculosis in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• RNA-based tuberculosis vaccine 1 (investigational)
• RNA-based tuberculosis vaccine 2 (investigational)

Snippet

Sponsor: BioNTech SE | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED